Nyapati Venkata Satya Giridhar
About Nyapati Venkata Satya Giridhar
Data last updated:
Nyapati Venkata Satya Giridhar is a Director at Saisun Pharma Private Limited (since 2003), Director at Erotas Life Sciences Private Limited (since 2023) and Director at Aaspada Enterprises Private Limited (since 2015). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹111 Cr; the largest is Saisun Pharma Private Limited at ₹110 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saisun Pharma Private Limited U24231DL2003PTC121103 | Director | 27 Jun 2003 | 2003 | ₹110 Cr (FY 2025) | Active |
| Erotas Life Sciences Private Limited U46497TS2023PTC174322 | Director | 23 Jun 2023 | 2023 | ₹23.8 Lakh (FY 2025) | Active |
| Aaspada Enterprises Private Limited U74900DL2015PTC279275 | Director | 20 Apr 2015 | 2015 | Active |
Board colleagues of Nyapati Venkata Satya Giridhar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanal Kumar Kuttikkat | 00839387 | Saisun Pharma Private Limited , Aaspada Enterprises Private Limited | Director |
| Asis Kumar Behera | 05216237 | Erotas Life Sciences Private Limited , Aaspada Enterprises Private Limited | Director |
| Manju Narahari | 06449334 | Erotas Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nyapati Venkata Satya Giridhar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nyapati Venkata Satya Giridhar
Nyapati Venkata Satya Giridhar currently holds 3 directorships: Saisun Pharma Private Limited (Director, since 27 Jun 2003, revenue ₹110 Cr (FY 2025)); Erotas Life Sciences Private Limited (Director, since 23 Jun 2023, revenue ₹23.8 Lakh (FY 2025)); Aaspada Enterprises Private Limited (Director, since 20 Apr 2015).
Nyapati Venkata Satya Giridhar was first appointed on 27 Jun 2003 as Director at Saisun Pharma Private Limited. The most recent appointment on record is 23 Jun 2023 at Erotas Life Sciences Private Limited.
The 2 current companies of Nyapati Venkata Satya Giridhar that report revenue have a combined latest revenue of ₹111 Cr: Saisun Pharma Private Limited ₹110 Cr (FY 2025); Erotas Life Sciences Private Limited ₹23.8 Lakh (FY 2025).
The current boards of Nyapati Venkata Satya Giridhar's companies include Sanal Kumar Kuttikkat (Saisun Pharma Private Limited), Asis Kumar Behera (Erotas Life Sciences Private Limited), Manju Narahari (Erotas Life Sciences Private Limited).